An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays

被引:398
作者
Zhao, XJ
Li, C
Paez, JG
Chin, K
Jänne, PA
Chen, TH
Girard, L
Minna, J
Christiani, D
Leo, C
Gray, JW
Sellers, WR
Meyerson, M
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA
[7] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[8] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75230 USA
[9] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75230 USA
[10] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA
关键词
D O I
10.1158/0008-5472.CAN-03-3308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Changes in DNA copy number contribute to cancer pathogenesis. We now show that high-density single nucleotide polymorphism (SNP) arrays can detect copy number alterations. By hybridizing genomic representations of breast and lung carcinoma cell line and lung tumor DNA to SNP arrays, and measuring locus-specific hybridization intensity, we detected both known and novel genomic amplifications and homozygous deletions in these cancer samples. Moreover, by combining genotyping with SNP quantitation, we could distinguish loss of heterozygosity events caused by hemizygous deletion from those that occur by copy-neutral events. The simultaneous measurement of DNA copy number changes and loss of heterozygosity events by SNP arrays should strengthen our ability to discover cancer-causing genes and to refine cancer diagnosis.
引用
收藏
页码:3060 / 3071
页数:12
相关论文
共 32 条
[1]   Genomic microarrays in human genetic disease and cancer [J].
Albertson, DG ;
Pinkel, D .
HUMAN MOLECULAR GENETICS, 2003, 12 :R145-R152
[2]   EXPRESSION OF RECESSIVE ALLELES BY CHROMOSOMAL MECHANISMS IN RETINOBLASTOMA [J].
CAVENEE, WK ;
DRYJA, TP ;
PHILLIPS, RA ;
BENEDICT, WF ;
GODBOUT, R ;
GALLIE, BL ;
MURPHREE, AL ;
STRONG, LC ;
WHITE, RL .
NATURE, 1983, 305 (5937) :779-784
[3]   ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
KRAUS, MH ;
SEGATTO, O ;
KING, CR ;
AARONSON, SA .
SCIENCE, 1987, 237 (4811) :178-182
[4]  
Dugad R., 1996, SPANN961
[5]   A HUMAN DNA SEGMENT WITH PROPERTIES OF THE GENE THAT PREDISPOSES TO RETINOBLASTOMA AND OSTEOSARCOMA [J].
FRIEND, SH ;
BERNARDS, R ;
ROGELJ, S ;
WEINBERG, RA ;
RAPAPORT, JM ;
ALBERT, DM ;
DRYJA, TP .
NATURE, 1986, 323 (6089) :643-646
[6]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[7]  
Hoque MO, 2003, CANCER RES, V63, P2216
[8]   High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines [J].
Jänne, PA ;
Li, C ;
Zhao, XJ ;
Girard, L ;
Chen, TH ;
Minna, J ;
Christiani, DC ;
Johnson, BE ;
Meyerson, M .
ONCOGENE, 2004, 23 (15) :2716-2726
[9]   COMPARATIVE GENOMIC HYBRIDIZATION FOR MOLECULAR CYTOGENETIC ANALYSIS OF SOLID TUMORS [J].
KALLIONIEMI, A ;
KALLIONIEMI, OP ;
SUDAR, D ;
RUTOVITZ, D ;
GRAY, JW ;
WALDMAN, F ;
PINKEL, D .
SCIENCE, 1992, 258 (5083) :818-821
[10]   A CELL-CYCLE REGULATOR POTENTIALLY INVOLVED IN GENESIS OF MANY TUMOR TYPES [J].
KAMB, A ;
GRUIS, NA ;
WEAVERFELDHAUS, J ;
LIU, QY ;
HARSHMAN, K ;
TAVTIGIAN, SV ;
STOCKERT, E ;
DAY, RS ;
JOHNSON, BE ;
SKOLNICK, MH .
SCIENCE, 1994, 264 (5157) :436-440